162 related articles for article (PubMed ID: 25324001)
1. Cholinergic receptors as target for cancer therapy in a systems medicine perspective.
Russo P; Del Bufalo A; Milic M; Salinaro G; Fini M; Cesario A
Curr Mol Med; 2014; 14(9):1126-38. PubMed ID: 25324001
[TBL] [Abstract][Full Text] [Related]
2. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
3. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
[TBL] [Abstract][Full Text] [Related]
4. Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton.
Bencherif M; Lukas RJ
J Neurochem; 1993 Sep; 61(3):852-64. PubMed ID: 8360687
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of synergy of corneal muscarinic and nicotinic acetylcholine receptors in upregulation of E-cadherin expression.
Chernyavsky AI; Galitovskiy V; Grando SA
Int Immunopharmacol; 2015 Nov; 29(1):15-20. PubMed ID: 25957200
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptors: Key players in cancer development.
Chen J; Cheuk IWY; Shin VY; Kwong A
Surg Oncol; 2019 Dec; 31():46-53. PubMed ID: 31536927
[TBL] [Abstract][Full Text] [Related]
7. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function.
Kawashima K; Fujii T
Front Biosci; 2004 Sep; 9():2063-85. PubMed ID: 15353271
[TBL] [Abstract][Full Text] [Related]
8. M2 muscarinic ACh receptors sensitive BK channels mediate cholinergic inhibition of type II vestibular hair cells.
Guo CK; Wang Y; Zhou T; Yu H; Zhang WJ; Kong WJ
Hear Res; 2012 Mar; 285(1-2):13-9. PubMed ID: 22366501
[TBL] [Abstract][Full Text] [Related]
9. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
10. Bladder outlet obstruction influences mRNA expression of cholinergic receptors on sensory neurons in mice.
Bschleipfer T; Nandigama R; Moeller S; Illig C; Weidner W; Kummer W
Life Sci; 2012 Nov; 91(21-22):1077-81. PubMed ID: 22634327
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of ACh receptors on the heart of the marine bivalve Meretrix lusoria.
Lee CM; Lin JT; Hwang JC
Chin J Physiol; 1998; 41(1):19-24. PubMed ID: 9629478
[TBL] [Abstract][Full Text] [Related]
12. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy.
Fujii T; Takada-Takatori Y; Kawashima K
J Pharmacol Sci; 2008 Feb; 106(2):186-92. PubMed ID: 18285654
[TBL] [Abstract][Full Text] [Related]
13. Expression and Function of the Cholinergic System in Immune Cells.
Fujii T; Mashimo M; Moriwaki Y; Misawa H; Ono S; Horiguchi K; Kawashima K
Front Immunol; 2017; 8():1085. PubMed ID: 28932225
[TBL] [Abstract][Full Text] [Related]
14. Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells.
Dickinson JA; Hanrott KE; Mok MH; Kew JN; Wonnacott S
J Neurochem; 2007 Feb; 100(4):1089-96. PubMed ID: 17181555
[TBL] [Abstract][Full Text] [Related]
15. [An independent, non-neuronal cholinergic system in lymphocytes and its roles in regulation of immune function].
Fujii T
Nihon Yakurigaku Zasshi; 2004 Mar; 123(3):179-88. PubMed ID: 14993730
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of cholinergic receptors in small cell lung cancer cells.
Zhang S; Togo S; Minakata K; Gu T; Ohashi R; Tajima K; Murakami A; Iwakami S; Zhang J; Xie C; Takahashi K
Anticancer Res; 2010 Jan; 30(1):97-106. PubMed ID: 20150622
[TBL] [Abstract][Full Text] [Related]
17. Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy.
Song P; Spindel ER
J Pharmacol Sci; 2008 Feb; 106(2):180-5. PubMed ID: 18285655
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor agonists and antagonists: effects on cancer.
Spindel ER
Handb Exp Pharmacol; 2012; (208):451-68. PubMed ID: 22222710
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.
Holt JC; Kewin K; Jordan PM; Cameron P; Klapczynski M; McIntosh JM; Crooks PA; Dwoskin LP; Lysakowski A
J Neurosci; 2015 Feb; 35(8):3625-43. PubMed ID: 25716861
[TBL] [Abstract][Full Text] [Related]
20. Variation of nicotinic subtype α7 and muscarinic subtype M3 acetylcholine receptor expression in three main types of leukemia.
Suriyo T; Chotirat S; Auewarakul CU; Chaiyot K; Promsuwicha O; Satayavivad J
Oncol Lett; 2019 Jan; 17(1):1357-1362. PubMed ID: 30655906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
